Deal● Neutral for Indian equities
KKR-owned Healthium, Temasek-backed Romsons in race to buy 70-80% stake in BL Lifesciences
The brief
- KKR-owned Healthium Medtech and Temasek-backed Romsons Group are competing to buy a 70-80% stake in BL Lifesciences